Kluster Kepakaran/ Cluster of Expertise :
Kesihatan dan Perubatan Termaju,
Biografi/ Biography :
Dr. Kok-Yong Chin adalah seorang pensyarah kanan di Jabatan Farmakologi, Fakulti Perubatan, Universiti Kebangsaan Malaysia. Minat penyelidikannya merangkumi epidemiologi kesihatan tulang, penuaan lelaki, metabolisme tulang, dan penggunaan vitamin E dalam merawat penyakit muskuloskeletal. Beliau adalah pengarang/bersama pengarang lebih daripada 220 artikel jurnal. Indeks h beliau kini berada pada 39, menurut Scopus. Beliau memenangi Anugerah Penyelidik Muda di Persidangan Ke-32 Persatuan Farmakologi dan Fisiologi Malaysia pada tahun 2018, Persidangan Ke-5 Persekutuan Osteoporosis Asia pada tahun 2017, dan Persidangan International Conference on Advances in Medical Science pada tahun 2015. Beliau juga merupakan wakil Malaysia di Mesyuarat Pemenang Nobel Lindau ke-65 pada tahun 2015. Kini, beliau berkhidmat sebagai editor akademik untuk Journal of Tropical Life Science, editor bersekutu untuk BMC Public Health dan Frontiers in Endocrinology, serta ahli lembaga editorial untuk Medicine & Health. Beliau disenaraikan sebagai 2% saintis yang paling banyak dirujuk oleh Elsevier pada tahun 2021-2023.
Dr Kok-Yong Chin is a senior lecturer at the Department of Pharmacology, Faculty of Medicine, Universiti Kebangsaan Malaysia. His research interests include the epidemiology of bone health, male ageing, bone metabolism and the use of vitamin E in treating musculoskeletal diseases. He is the author/coauthor of more than 220 journal articles. His h-index currently stands at 39, according to Scopus. He won the Young Investigator Award at the 32nd Malaysian Society of Pharmacology and Physiology in 2018, the 5th Asian Federation of Osteoporosis Society Meeting in 2017, and the 1st International Conference of Advances in Medical Science in 2015. He was also a representative of Malaysia at the 65th Lindau Nobel Laureate Meeting in 2015. He currently serves as an academic editor of the Journal of Tropical Life Science, associate editor of BMC Public Health and Frontiers in Endocrinology, and an editorial board member of Medicine & Health. He is listed as the top 2% most cited scientist by Elsevier in 2021-2023.
kok-yong chin. (2026). vitamin k2 as a bone protective bioactive against osteoporosis and fragility fracture. - advances in biochemistry in health and d. 437 - 458.
yuanzhong wang, guiju chen, qin wang, bilin liu, qi he, xia huang, kok-yong chin. (2026). traditional medicine in a modern light: a scoping review on the osteoprotective potential of eucommia ulmoides. - frontiers in pharmacology. 1 - 19.
shabbir adnan shakir, kok-yong chin. (2026). effects of cannabidiol on bone health: a comprehensive scoping review. - biomedicines. 1 - 23.
nor amira nabila amir razak, jo aan goon, wan zurinah wan ngah, suzana makpol, nor faeizah ibrahim, nur fathiah abdul sani, kok yong chin, amilia aminuddin, mohd heikal mohd yunus, munirah md mansor. (2026). third interim report for a randomized, double-blinded, placebo-controlled study to evaluate the efficacy of oral supplementation of tocotrienol rich fraction (davoslife e3 complete). - . .
wenjian zhao, weizheng zhang, kok-yong chin, xiaodong ma, hashwin singh tejpal singh, sophia ogechi ekeuku, yuanzhong wang, xia ji, yang guo, sok kuan wong, norliza muhammad, teh rohaila jamil, saharuddin ahmad. (2026). adiposity indices and bone health amongst malaysian adults: evidence from a cross-sectional study. - experimental and therapeutic medicine. 1 - 8.
yuanzhong wang, guiju chen, qin wang, bilin liu, qi he, xia huang, kok-yong chin. (2026). traditional medicine in a modern light: a scoping review on the osteoprotective potential of eucommia ulmoides. - frontiers in pharmacology. 1 - 19.
shabbir adnan shakir, kok-yong chin. (2026). effects of cannabidiol on bone health: a comprehensive scoping review. - biomedicines. 1 - 23.
muhamad riduan daud, petrick periyasamy, kok-yong chin, najma kori, ummu afeera zainulabid, sheng qian yew, nur ezzaty mohammad kazmin, xiong khee cheong. (2026). low bone mineral density in men living with hiv on tenofovir antiretroviral therapy: a cross-sectional exploratory study from a malaysian tertiary hospital. - tropical medicine and infectious disease. 1 - 14.
yuanzhong wang, guiju chen, xia ji, sok kuan wong, sophia ogechi ekeuku & kok-yong chin. (2025). ejiao as a preventive agent for osteoporosis - a scoping review of current evidence. - journal of orthopaedic surgery and research. 1 - 16.
sophia ogechi ekeuku, shafiq zikry zarir, anis nazira razali, syamima mohamad zaidi, noor halinah mohamed ali jinnah, muhamed lahtif nor muhamad, sok kuan wong and kok-yong chin. (2025). palm tocotrienol preserves trabecular osteocyte indices and modulates the expression of osteocyte markers in ovariectomized rats. - biomedicines. 1 - 13.
wenjian zhao, weizheng zhang, kok-yong chin, xiaodong ma, hashwin singh tejpal singh, sophia ogechi ekeuku, yuanzhong wang, xia ji, yang guo, sok kuan wong, norliza muhammad, teh rohaila jamil, saharuddin ahmad. (2026). adiposity indices and bone health amongst malaysian adults: evidence from a cross-sectional study. - experimental and therapeutic medicine. 1 - 8.
siti norain azahar, chin kok yong, nur azlina mohd fahami, ibrahim abdel aziz ibrahim. (2025). pathogenesis of alcoholic fatty liver disease: molecular and cellular changes. - malaysian journal of pathology. 377 - 400.
yuanzhong wang, guiju chen, qin wang, zaifu zhou, wenjian zhao, sok kuan wong, tao wang, kok-yong chin. (2025). a comprehensive review of traditional chinese medicine ejiao (colla corii asini): chemical composition, quality control, and pharmacological actions. - natural product communications. 1 - 18.
lee, yee xin; lim, see meng; ng, xin qian; lum, pei teng; ramli, elvy suhana mohd; chin, kok-yong; budin, siti balkis. (2025). effects of low-protein diet on renal oxidative stress, biochemistry and histology in weaned rats. - sains malaysiana. 815 - 826.
wenjian zhao, yaomei long, yuanzhong wang and kok-yong chin. (2024). osteoarthritis: an integrative overview from pathogenesis to management. - malaysian journal of pathology. 369 - 378.
wenjian zhao, weizheng zhang, kok-yong chin, xiaodong ma, hashwin singh tejpal singh, sophia ogechi ekeuku, yuanzhong wang, xia ji, yang guo, sok kuan wong, norliza muhammad, teh rohaila jamil, saharuddin ahmad. (2026). adiposity indices and bone health amongst malaysian adults: evidence from a cross-sectional study. - experimental and therapeutic medicine. 1 - 8.
yuanzhong wang, guiju chen, qin wang, bilin liu, qi he, xia huang, kok-yong chin. (2026). traditional medicine in a modern light: a scoping review on the osteoprotective potential of eucommia ulmoides. - frontiers in pharmacology. 1 - 19.
shabbir adnan shakir, kok-yong chin. (2026). effects of cannabidiol on bone health: a comprehensive scoping review. - biomedicines. 1 - 23.
muhamad riduan daud, petrick periyasamy, kok-yong chin, najma kori, ummu afeera zainulabid, sheng qian yew, nur ezzaty mohammad kazmin, xiong khee cheong. (2026). low bone mineral density in men living with hiv on tenofovir antiretroviral therapy: a cross-sectional exploratory study from a malaysian tertiary hospital. - tropical medicine and infectious disease. 1 - 14.
michelle min-fang yee, kok-yong chin, soelaiman ima-nirwana, ekram alias, kien hui chua, sok kuan wong. (2025). evaluation of bone-protecting effects of palm carotene mixture in two- and three-dimensional osteoblast/osteoclast co-culture systems. - international journal of medical sciences. 585 - 603.
kok-yong chin. (2026). vitamin k2 as a bone protective bioactive against osteoporosis and fragility fracture. - advances in biochemistry in health and d. 437 - 458.
norazlina mohamed, norliza muhammad, noor azah abdul aziz, nor aini jamil @ a. wahab, mohd rizal abdul manaf, chan chin yi. (2024). kesedaran masyarakat terhadap kesihatan tulang dan sindrom metabolik. - . 37 - 42.
chin kok yong, ima nirwana soelaiman, fairus ahmad, wong sok kuan, ng pei yuen & shaanthana subramaniam. (2024). osteoporosis dan hubungkaitnya dengan sindrom metabolik. - . 27 - 36.
norzana abdul ghafar, norliza muhammad, yogeswaran lokanathan, chin kok yong & wong sok kuan. (2024). penuaan dan penyakit degeneratif. - . 14 - 26.
norazlina mohamed, chin kok yong. (2024). kaedah penuaan sihat secara saintifik. - . 11 - 13.
fairus ahmad, chin kok yong, khairun-nisa hashim. (2024). sesudu madu kelulut merahmati kesihatan. - . .
norazlina mohamed, norliza muhammad, noor azah abdul aziz, nor aini jamil @ a. wahab, mohd rizal abdul manaf, chan chin yi. (2024). kesedaran masyarakat terhadap kesihatan tulang dan sindrom metabolik. - . 37 - 42.
chin kok yong, ima nirwana soelaiman, fairus ahmad, wong sok kuan, ng pei yuen & shaanthana subramaniam. (2024). osteoporosis dan hubungkaitnya dengan sindrom metabolik. - . 27 - 36.
norzana abdul ghafar, norliza muhammad, yogeswaran lokanathan, chin kok yong & wong sok kuan. (2024). penuaan dan penyakit degeneratif. - . 14 - 26.
norazlina mohamed, chin kok yong. (2024). kaedah penuaan sihat secara saintifik. - . 11 - 13.
nor amira nabila amir razak, jo aan goon, wan zurinah wan ngah, suzana makpol, nor faeizah ibrahim, nur fathiah abdul sani, kok yong chin, amilia aminuddin, mohd heikal mohd yunus, munirah md mansor. (2026). third interim report for a randomized, double-blinded, placebo-controlled study to evaluate the efficacy of oral supplementation of tocotrienol rich fraction (davoslife e3 complete). - . .
xin qian ng, see meng lim, kok yong chin, elvy suhana mohd ramli, siti balkis budin. (2025). effects of a low protein diet on growth, body composition and bone health in weaning male and female rats. - 40th annual scientific conference of the nutrition society of malaysia. .
aswini kumareswaran, sophia ogechi ekeuku, norazlina mohamed, norliza muhammad, alfizah hanafiah, kok-lun pang, sok kuan wong, deborah chia hsin chew, kok-yong chin. (2025). the combination effects of orchidectomy and antibiotics on bone in male rats. - the 5th international conference on advances in medical science. .
ji xia, zhang huiying, kok-yong chin, wang yuanzhong, abdul kadir abdul karim. (2025). a scoping review of the effects of imatinib on male reproductive gonads. - the 5th international conference on advances in medical science. .
xin qian ng, see meng lim, kok-yong chin, elvy suhana mohd ramli, siti balkis budin. (2025). sex-specific effects of a cricket-based diet on growth, body composition and bone parameters in protein-deficient male and female juvenile sprague-dawley rats. - asian insect industry & research forum 2025 . .
| Geran / Grant | Kolaborator / Collaborator | Status |
|---|---|---|
| INVESTIGATING THE GUT-LUNG AXIS INTERACTION OF LIGNOSUS RHINOCEROTIS (TIGER MILK MUSHROOM) IN REDUCING COUGH AND LUNG INFLAMMATION | nexus wise sdn bhd | 69.3% (2024-01-31 sehingga 2026-12-31) |
| TOCOTRIENOL AS A SENOLYTIC AGENT: A PHASE 2 CLINICAL TRIAL | malaysian palm oil board | 76.6% (2022-11-29 sehingga 2027-01-30) |
| TOCOTRIENOL AS A SENOLYTIC AGENT: A PHASE 2 CLINICAL TRIAL | davos life science sdn bhd | 76.6% (2022-11-29 sehingga 2027-01-30) |
| KESAN KETOKSIKAN BAHAN PSIKOAKTIF BAHARU (NPS) TERPILIH TERHADAP ORGAN UTAMA FUNGSI TUBUH | jabatan siasatan jenayah narkotik, polis diraja malaysia | 45.2% (2024-10-01 sehingga 2027-09-30) |
| ELUCIDATING THE EFFECT OF MITOCHONDRIA FUNCTION ON METABOLOMIC AND LIPIDOMIC CHANGES IN THE LIVER DURING AGEING AND ITS MODULATION BY GINGER EXTRACT | genomax technologies sdn bhd | 68.8% (2025-01-28 sehingga 2026-07-27) |
| INVESTIGATING THE EFFECTS OF DELTA-TOCOTRIENOL AND VITAMIN K2 CO-SUPPLEMENTATION IN PREVENTING OSTEOPOROSIS IN A RAT MODEL OF OESTROGEN DEFICIENCY | american river nutrition | 68.8%(2024-11-01 sehingga 2026-10-31) |
| THE EFFECT OF PALM TOCOTRIENOL RICH FRACTION ON ALCOHOLIC FATTY LIVER DISEASE (AFLD): A PHASE II CLINICAL TRIAL | malaysian palm oil board (mpob) | 68.8%(2021-11-11 sehingga 2026-12-15) |
| THE EFFECT OF PALM TOCOTRIENOL RICH FRACTION ON ALCOHOLIC FATTY LIVER DISEASE (AFLD): A PHASE II CLINICAL TRIAL | excelvite sdn. bhd | 68.8%(2021-11-11 sehingga 2026-12-15) |
| THE EFFECT OF PALM TOCOTRIENOL RICH FRACTION ON ALCOHOLIC FATTY LIVER DISEASE (AFLD): A PHASE II CLINICAL TRIAL | hovid berhad | 68.8%(2021-11-11 sehingga 2026-12-15) |
BASIC MEDICAL SCIENCES :CLINICAL AND HEALTH SCIENCES
Osteoporosis
Pengalaman / Experience : tahun/years(s)
PHARMACOLOGY :CLINICAL AND HEALTH SCIENCES
Osteoporosis
Pengalaman / Experience : tahun/years(s)
PHARMACOLOGY :CLINICAL AND HEALTH SCIENCES
Osteoporosis and Bone Metabolism
Pengalaman / Experience : 5 tahun/years(s)
BASIC MEDICAL SCIENCES :CLINICAL AND HEALTH SCIENCES
Animal models of osteoporosis, osteoarthritis
Pengalaman / Experience : 5 tahun/years(s)